Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural lesotho.

Bygrave, Helen; Kranzer, Katharina; Hilderbrand, Katherine; Jouquet, Guillaume; Goemaere, Eric; Vlahakis, Nathalie; Triviño, Laura; Makakole, Lipontso; Ford, Nathan

dc.contributor.author	Bygrave, Helen
dc.contributor.author	Kranzer, Katharina
dc.contributor.author	Hilderbrand, Katherine
dc.contributor.author	Jouquet, Guillaume
dc.contributor.author	Goemaere, Eric
dc.contributor.author	Vlahakis, Nathalie
dc.contributor.author	Triviño, Laura
dc.contributor.author	Makakole, Lipontso
dc.contributor.author	Ford, Nathan
dc.date.accessioned	2011-03-24T16:00:58Z
dc.date.available	2011-03-24T16:00:58Z
dc.date.issued	2011-03
dc.identifier.citation	Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural lesotho. 2011, 6 (3):e17609 PLoS ONE	en
dc.identifier.issn	1932-6203
dc.identifier.pmid	21407815
dc.identifier.doi	10.1371/journal.pone.0017609
dc.identifier.uri	http://hdl.handle.net/10144/125587
dc.description.abstract	Current guidelines contraindicate TDF use when creatinine clearance (CrCl) falls below 50 ml/min. We report prevalence of abnormal renal function at baseline and factors associated with abnormal renal function from a community cohort in Lesotho.
dc.language.iso	en	en
dc.rights	Published by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permission	en
dc.title	Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural lesotho.	en
dc.contributor.department	Médecins Sans Frontières, Morija, Lesotho.	en
dc.identifier.journal	PloS One	en
refterms.dateFOA	2019-03-04T08:39:06Z
html.description.abstract	Current guidelines contraindicate TDF use when creatinine clearance (CrCl) falls below 50 ml/min. We report prevalence of abnormal renal function at baseline and factors associated with abnormal renal function from a community cohort in Lesotho.